Publication | Closed Access
Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells.
102
Citations
38
References
2012
Year
This approach could offer a new chemotherapy strategy for patients diagnosed with unresectable hepatocellular carcinoma (HCC).
| Year | Citations | |
|---|---|---|
Page 1
Page 1